http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110256465-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate | 2019-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110256465-B |
| titleOfInvention | 2, 4-diaminopyrimidine containing dihydropyranothiazole and application thereof |
| abstract | The invention relates to 2, 4-diaminopyrimidine containing dihydropyranothiazole, wherein the chemical structure of the 2, 4-diaminopyrimidine is shown as the following formula (I), and in the formula (I), R is amino or methyl. The dihydropyranothiazole-containing 2, 4-diaminopyrimidine can inhibit Cyclin Dependent Kinases (CDKs), particularly CDK2, and has a remarkable effect of controlling the proliferation of cervical, colon and liver tumor cells. |
| priorityDate | 2019-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 136.